Bioengineered Skin Substitutes Market Report 2026

Bioengineered Skin Substitutes Market Overview

• Bioengineered Skin Substitutes market size has reached to $2.48 billion in 2025 • Expected to grow to $4.66 billion in 2030 at a compound annual growth rate (CAGR) of 13.4% • Growth Driver: Rising Number Of Burn Cases Is Driving The Growth Of The Bioengineered Skin Substitutes Market. • Market Trend: Advancements In Bioengineered Skin Substitutes Enhanced Market Growth • North America was the largest region in 2025.

What Is Covered Under Bioengineered Skin Substitutes Market?

Bioengineered skin substitutes are artificial or lab-grown skin materials that are developed using biological, synthetic, or a combination of both materials to replicate the function and structure of human skin. These substitutes are primarily used for treating severe skin injuries or conditions that require skin replacement or regeneration, such as burns, chronic wounds, ulcers, or reconstructive surgeries. The main products of bioengineered skin substitutes are acellular, allogeneic, xenogeneic, autologous, and others. Acellular skin substitutes are products made from skin tissues that have all cells removed, leaving only the structure. The various applications where these are applied are acute wounds and chronic wounds, are for different end users, including wound care centers, hospitals, specialty clinics, and others.

What Is The Bioengineered Skin Substitutes Market Growth Forecast?

The bioengineered skin substitutes market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2030 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for regenerative medicine solutions, rising adoption of personalized wound care therapies, expansion of aging population with chronic wounds, growing investments in tissue engineering research, increasing clinical acceptance of bioengineered skin substitutes. Major trends in the forecast period include increasing adoption of bioactive skin regeneration products, rising use of advanced wound healing materials, growing demand for chronic wound treatment solutions, expansion of personalized skin grafting techniques, enhanced focus on biocompatibility and healing outcomes.

What Is The Driver Of The Bioengineered Skin Substitutes Market?

The rising number of burn cases is expected to propel the growth of the bioengineered skin substitute market going forward. Burn cases refer to injuries caused by skin or other organic tissue damage, primarily due to heat, radiation, electricity, friction, or chemicals. The burn cases are caused due to inadequate safety measures, irresponsible use of flammable materials, and lack of awareness about fire hazards and proper safety protocols. Bioengineered skin substitutes provide a temporary or permanent replacement for damaged skin, promoting healing, reducing the risk of infection, and improving functional and cosmetic outcomes. For instance, in October 2023, according to the International Burn Injury Database (iBID), a UK-based national registry covering all national health service (NHS) specialised burn services in England and Wales, burn and scald injuries to children in the first six months of 2023 increased by 45% compared with the same period in 2022, and burns and scalds to adults and the elderly from hot water bottles rose by 19%. Therefore, the rising number of burn cases is driving the growth of the bioengineered skin substitute industry.

Key Players In The Global Bioengineered Skin Substitutes Market

Major companies operating in the bioengineered skin substitutes market are Smith & Nephew Plc, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation, Gunze Limited, Organogenesis Inc., LifeNet Health Inc., MiMedx Group Inc., Vericel Corporation, AlloSource Inc., Sientra Inc., PolyNovo Limited, Avita Medical Limited, Tissue Regenix Group, Amarantus Bioscience Holdings Inc., PolarityTE, Promethean LifeSciences Inc., Medline Industries, Mölnlycke Health Care, DermTech Inc., Acelity Inc., Kerecis, Stratatech Corporation

Global Bioengineered Skin Substitutes Market Trends and Insights

Major companies operating in the bioengineered skin substitute market are developing fish skin grafts to enhance the effectiveness and versatility of skin substitutes. A fish-skin graft is a wound-healing material made from processed fish skin that helps support tissue regeneration and repair. For instance, in February 2024, Kerecis, an Iceland-based wound care company, launched Shield Standard, a bioengineered skin substitute that combines intact fish skin with a silicone backing. It is sourced from fish skin, serving as a natural scaffold for healing. Kerecis employs patented technology that uses minimal processing to retain the beneficial components of fish skin that enhance tissue regeneration. It offers unique features such as biocompatibility with human skin, natural moisture retention, and the ability to reduce the risk of infection, making it a promising option for treating various types of wounds, including chronic and acute injuries.

What Are Latest Mergers And Acquisitions In The Bioengineered Skin Substitutes Market?

In August 2023, Coloplast A/S, a Denmark-based healthcare company, acquired Kerecis for $1.3 billion. Through this acquisition, Coloplast aims to strengthen its position in the advanced wound care market, particularly in the high-growth US-centric biologics segment. Kerecis is an Iceland-based manufacturer of skin-based therapeutic products for fish, which involve bioengineered skin substitutes.

What Defines the Bioengineered Skin Substitutes Market?

The bioengineered skin substitutes market consists of sales of products including apligraf, dermagraft, epicel, transcyte, and orcel. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioengineered Skin Substitutes Market Report 2026?

The bioengineered skin substitutes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioengineered skin substitutes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.